These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure. Grobner T, Prischl FC. Semin Dial; 2008 Feb; 21(2):135-9. PubMed ID: 18226001 [Abstract] [Full Text] [Related]
23. Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark. Elmholdt TR, Pedersen M, Jørgensen B, Søndergaard K, Jensen JD, Ramsing M, Olesen AB. Br J Dermatol; 2011 Oct; 165(4):828-36. PubMed ID: 21692765 [Abstract] [Full Text] [Related]
26. The debate between gadolinium versus erythropoietin in a renal transplant patient with nephrogenic systemic fibrosis. Hashemi P, Sina B, Rietkerk W, Safai B. J Nephrol; 2013 Oct; 26(1):48-54. PubMed ID: 22573525 [Abstract] [Full Text] [Related]
27. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review. Sanyal S, Marckmann P, Scherer S, Abraham JL. Nephrol Dial Transplant; 2011 Nov; 26(11):3616-26. PubMed ID: 21441397 [Abstract] [Full Text] [Related]
34. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Broome DR. Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138 [Abstract] [Full Text] [Related]
37. Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital. Zou Z, Ma L, Li H. J Magn Reson Imaging; 2009 Dec; 30(6):1309-12. PubMed ID: 19937931 [Abstract] [Full Text] [Related]
38. Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options. Schieren G, Wirtz N, Altmeyer P, Rump LC, Weiner SM, Kreuter A. J Am Acad Dermatol; 2009 Nov; 61(5):868-74. PubMed ID: 19836645 [Abstract] [Full Text] [Related]
39. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy. Foss C, Smith JK, Ortiz L, Hanevold C, Davis L. Pediatr Dermatol; 2009 Nov; 26(5):579-82. PubMed ID: 19840315 [Abstract] [Full Text] [Related]
40. Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate. Kadiyala D, Roer DA, Perazella MA. Am J Kidney Dis; 2009 Jan; 53(1):133-7. PubMed ID: 19022548 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]